Position in REGN
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$334,840
New position
Shares Held
537
first reported quarter
Ownership
0.001%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#911
of 1,322 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Jun 30, 202617 CAPITAL PARTNERS, LLC holds $838,524 across 2 Biotechnology names. REGN ranks #2 (39.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,014 | $503,684 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
This page
|
537 | $334,840 |
All Filings in REGN
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $334,840 | 537 | Shares | Sole | 2026-08-06 | |
| No filing history on record for this holder in this stock. | ||||||